Invention Grant
- Patent Title: Benzodiazepine derivatives as RSV inhibitors
-
Application No.: US16821290Application Date: 2020-03-17
-
Publication No.: US11254664B2Publication Date: 2022-02-22
- Inventor: Kaicheng Zhu , Kevin McGrath , Solymar Negretti-Emmanuelli , Adam Szymaniak , Jianming Yu , In Jong Kim , Yat Sun Or
- Applicant: ENANTA PHARMACEUTICALS, INC.
- Applicant Address: US MA Watertown
- Assignee: ENANTA PHARMACEUTICALS, INC.
- Current Assignee: ENANTA PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: C07D243/12
- IPC: C07D243/12 ; A61K31/55 ; C07D413/14 ; A61P31/14 ; C07D417/14 ; A61K45/06 ; A61K31/5513
Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Public/Granted literature
- US20200299286A1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS Public/Granted day:2020-09-24
Information query
